ClinicalTrials.Veeva

Menu
A

AGA Clinical Trials | Hialeah, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rimegepant
Pregabalin
HYD
Hydrocodone Bitartrate
Peramivir
ASC10
Palovarotene
NB-001
LY2951742
Seltorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 40 total trials

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo
Status recently updated

The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants wit...

Not yet enrolling
Enrolling
Healthy
Rheumatoid Arthritis (RA)
Drug: LY4213663
Drug: Placebo

The main aim of this study is to understand how moderate and severe liver impairment (based on the Child-Pugh classification) affects the body's proc...

Enrolling
Hepatic Impairment
Healthy
Drug: Palovarotene

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or...

Enrolling
Chronic Migraine
Episodic Migraine
Biological: IPN10200 dose B
Biological: IPN10200

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic...

Active, not recruiting
Chronic Migraine
Other: Placebo
Biological: Botulinum toxin type A

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing episodic...

Active, not recruiting
Episodic Migraine
Other: Placebo
Biological: Botulinum toxin type A

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 yea...

Enrolling
Dermatitis Atopic
Drug: Placebo
Drug: Amlitelimab

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Enrolling
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared wi...

Enrolling
Osteoarthritis, Knee
Drug: Pentosan Polysulfate Sodium twice weekly
Drug: Placebo

The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with plac...

Enrolling
Depressive Disorder, Major
Drug: Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Drug: Placebo

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

Trial sponsors

Pfizer logo
Ipsen logo
Lilly logo
Gilead Sciences logo
Purdue Pharma logo
Viatris logo
A
AbbVie logo
Akebia Therapeutics logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems